aruka inhibition with vic-1911 potentiates krasg12ci and overcomes resistance: what's next?
Published 2 years ago • 43 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
2:00
aurora a kinase inhibition with vic-1911 potentiates krasg12ci and overcomes resistance
-
0:31
mechanism of action of the novel krasg12c inhibitor gdc-6036
-
1:42
next-generation alk inhibitors: treatment sequencing and resistance
-
0:44
ascertaining the mechanisms of resistance to krasg12c inhibitors
-
1:12
overcoming resistance to kras g12c inhibitors in nsclc
-
3:17
mechanisms of resistance to kras g12c inhibitors
-
1:31
optimizing and overcoming resistance to current kras inhibitors
-
0:39
the rationale behind targeting aurora a kinase in lung cancer
-
1:38
handling covid-19 complexities in anemia and hematological malignancy patients
-
49:16
"the future of the brightest x-ray sources" by zhirong huang (slac national accelerator laboratory)
-
3:27
how does an x-ray tube work (radiation protection)
-
3:44
alk inhibitors for acquired resistance: zykadia and alectinib
-
1:00
risk calculator aids doctors in diagnosing coronary artery disease
-
4:11
crossroads: terrible topology -- extrachromosomal circular dna in cancer
-
5:23
kras g12c inhibitors: acquired resistance and combo strategies
-
0:42
x-ray aprons: front protection vs full protection
-
1:48
ask ruby: what is kras?
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
2:04
acquired resistance to osimertinib in t790m-positive nsclc
-
1:47
updates on biomarkers of resistance to crc treatment